![Christian Pangratz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christian Pangratz
Algemeen Directeur bij Atriva Therapeutics GmbH
Actieve functies van Christian Pangratz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Algemeen Directeur | 15-01-2023 | - |
Loopbaan van Christian Pangratz
Eerdere bekende functies van Christian Pangratz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Vectura GmbH
![]() Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Corporate Officer/Principal | 23-05-2013 | 01-09-2014 |
Verkoop & Marketing | 01-04-2011 | 23-05-2013 | |
sterna biologicals GmbH
![]() sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Sterna Biologicals GmbH is a German clinical-stage immunology company founded in 2006. The company is based in Marburg, Germany. The company has successfully completed four phase 2a clinical trials in asthma, ulcerative colitis, COPD, and atopic dermatitis. Sterna is focused on developing novel treatments for type 2 chronic inflammatory diseases. | Algemeen Directeur | - | - |
SKYEPHARMA PLC | Corporate Officer/Principal | 01-10-2014 | - |
Vienna GmbH
![]() Vienna GmbH Financial ConglomeratesFinance Vienna GmbH operates as an investment firm. The company was founded by Bartolo Vienna in 1984 and is headquartered in Wallhausen, Germany. | Corporate Officer/Principal | - | - |
Pfizer GmbH | Corporate Officer/Principal | - | - |
BAYER AG | Corporate Officer/Principal | - | - |
NEKTAR THERAPEUTICS | Corporate Officer/Principal | - | - |
Opleiding van Christian Pangratz
Webster University | Graduate Degree |
Statistieken
Internationaal
Duitsland | 7 |
Verenigde Staten | 3 |
Verenigd Koninkrijk | 2 |
Operationeel
Corporate Officer/Principal | 6 |
Chief Executive Officer | 2 |
Sales & Marketing | 1 |
Sectoraal
Health Technology | 7 |
Consumer Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
BAYER AG | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
SkyePharma Plc
![]() SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
Pfizer GmbH | |
Vienna GmbH
![]() Vienna GmbH Financial ConglomeratesFinance Vienna GmbH operates as an investment firm. The company was founded by Bartolo Vienna in 1984 and is headquartered in Wallhausen, Germany. | Finance |
Atriva Therapeutics GmbH
![]() Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
sterna biologicals GmbH
![]() sterna biologicals GmbH Pharmaceuticals: MajorHealth Technology Sterna Biologicals GmbH is a German clinical-stage immunology company founded in 2006. The company is based in Marburg, Germany. The company has successfully completed four phase 2a clinical trials in asthma, ulcerative colitis, COPD, and atopic dermatitis. Sterna is focused on developing novel treatments for type 2 chronic inflammatory diseases. | Health Technology |
Vectura GmbH
![]() Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
- Beurs
- Insiders
- Christian Pangratz
- Ervaring